SlideShare une entreprise Scribd logo
1  sur  25
Télécharger pour lire hors ligne
Drugs Affecting The
Autonomic Nervous System
DR.JAMA
•Introduction to Nervous
system
2
NERVOUS SYSTEM
•The nervous system is divided into two parts: the
central nervous system (CNS) and the
peripheral nervous system (PNS).
•The CNS consists of the brain and spinal cord.
•The PNS consists of afferent(sensory) and
efferent(motor) neurons.
•Afferent (sensory) neurons carry nerve impulses
into the CNS from sensory end organs.
•Efferent (motor) neurons carry nerve impulses
from the CNS to effector cells in peripheral
tissues.
Cont…
•The peripheral efferent system is further
divided into the somatic nervous system and
the autonomic nervous system which control
voluntary and involuntary functions
respectively
•The autonomic nervous system is subdivided
into two major sub-divisions; this
classification is based on both anatomic and
physiologic grounds:
• Sympathetic (Adrenergic)Nervous System(SNS)
• Parasympathetic (Cholinergic) Nervous System(PNS)
The Autonomic Nervous System
Sympathetic (Adrenergic) N S
• Arises from thoracic &
lumbar areas of the spinal
cord.
• Concerned with the
expenditure of energy & it is
associated with arousal or
emergency situations, i.e.
prepares the body for fight
or flight responses
Parasympathetic (Cholinergic) N S
• Arises from the cranial and
sacral of the spinal cord.
• Concerned with the
conservative & restoration of
functions, i.e. prepare the
body for rest
• Digestive processes &
elimination of wastes, and is
required for life.
Nerve Transmission
•There are two important neurotransmitters in the
autonomic nervous system.
• Acetylcholine and
• Noradrenaline (norepinephrine)
•Acetylcholine
• Released after stimulation of the PNS to act
•On effector organs (cells) to elicit their response
•As a neurotransmitter:
• At all preganglionic neurons of both SNS & PNS
Cont…
• The effect of PNS activity in an organ is produced either by
•Stimulation of a parasympathetic nerve fibers
supplying the organ or
•The application of acetylcholine or other
parasympathomimetics to the effector cells.
•This is known as cholinergic activity.
•Norepinephrine
•Released by postganglionic sympathetic nerves to
elicit its effect on effectors cells.
•Acts as a neurotransmitters at
•Most postganglionic sympathetic nerve ending
•Adrenal medullary nerve ending
Cont…
•Sympathetic nerve activity is produced by
•Sympathetic nerve stimulation or
•Application of noradrenaline or adrenaline or
other sympathomimetics, i.e. ‘adrenergic
activity.
• These neurotransmitters have different receptors but there are
two basic categories of receptors associated with the ANS:
•Cholinergic receptors: M and N receptors
•Adrenergic receptors: Alpha and Beta
Cont…
Cholinergic receptors
• Are those receptors that mediate responses to acetylcholine
• Cholinergic receptors for Ach are classified into
• Muscarinic R.( most autonomic effector cells)
• Nicotinic R.( ganglia and skeletal muscles)
Adrenergic receptors
• Are those receptors that mediate responses to
norepinephrine
• Adrenergic receptors for norepinephrine are
•Alpha R.(α)
•Beta R.(β)
•Agents that increase the activity of Ach or stimulate
Parasympathetic nerve system are known as
Parasympathomimetics or Cholinergic agonist
•Those work against this are known as Parasympatholytics
or Anticholinergics
•The agents which increase the activity of Epinephrine and
norepinephrine are known as sympathomimetics or
Adrenergic agonists
•and those which oppose are called Sympatholytics or
Adrenergic antagonists
13
Drugs Acting on Parasympathetic(Cholinergic)
system
Neurotransmission at Cholinergic Neurons
Neurotransmission in cholinergic neurons involves six
steps:
1) Synthesis,
2) Storage,
3) Release,
4) Binding of acetylcholine to a receptor,
5) Degradation of the neurotransmitter in the synaptic cleft
(that is, the space between the nerve endings and adjacent
receptors located on nerves or effector organs),
6) Recycling of choline and acetate
14
Cholinergic Receptors
A. Muscarinic receptors
They have high affinity for muscarine and low affinity for
Nicotine
There are five subclasses of muscarinic receptors.
However, only M1, M2, and M3 receptors have been
functionally characterized.
Locations
Ganglia of PNS and autonomic effector organ such as Heart
, smooth muscle, brain, Exocrine glands
M1: Gastric parietal cell
M2: Cardiac smooth muscle
M3: bladder, exocrine glands(sweat ,salivary), bronchial tree,
eye, gastrointestinal tract.
15
B) Nicotinic Receptors
Have high affinity for Nicotine and low affinity for
Muscarine
Located in
CNS, Adrenal medulla, Autonomic ganglia,
Neuromuscular junction NMJ in skeletal muscles
16
1. Cholinergic Agonists(Parasympathomimetics)
• Result in an increase in the parasympathetic activities in the systems
innervated by cholinergic nerves.
• There are two groups of cholinergic Agonists:
1. Direct-acting: bind to and activate muscarinic or nicotinic
receptors (mostly both) and include the following subgroups:
• Esters of choline: Acetylcholine, methacholine, carbachol,
betanechol
• Cholinergic alkaloids: pilocarpine, muscarine, nicotine
2. Indirect-acting: inhibit the action of acetylcholinesterase
enzyme
• Reversible: Neostigmine, physostigmine, Edrophonium
Pyridostigmine, ambenonium,
Tacrine, donepezil, rivastigmine, and galantamine
• Irreversible: Organophosphate compounds; Echothiophate,
17
Esters of choline
ACETYLCHOLINE
• It is the prototype of all cholinergic agents.
• It is ineffective if given orally, but given parenteral.
• MECHANISM OF ACTION(MOA):
• It has two types of actions: nicotinic and muscarinic; the
muscarinic actions are of main interest.
• CVS: slow HR, vasodilate Blood vessels(arterial smooth
muscle) thus decrease BP.
• GIT: It stimulates the tone and motility of the Gl tract but
relaxes the sphincters.
• Urinary tract: It stimulates the detrusor muscle and relaxes the
urethral sphincter resulting in evacuation of bladder.
• Bronchioles: It increase bronchial secretion and brings about
bronchoconstriction
18
•Eye: It has two effects- miosis and accommodation for
near objects because of stimulation of the constrictor
pupillae and ciliary muscles respectively.
•Exocrine glands: it stimulates salivary, gastric,
bronchial, lachrymal and sweat gland secretions.
19
Synthetic Choline Esters
•These Include:
•Metacholine
•Carbachol
•Betanechol
•These drugs have the following advantages over
acetylcholine:
They have longer duration of action,
They are effective orally as well as parenterally, and
They are relatively more selective in their actions
Betanechol
• MECHANISM OF ACTION(MOA):
•It has similar actions to those of acetylcholine with
pronounced effects on the GIT and the urinary bladder.
•Therapeutic uses:
•Retention of urine (postoperative, post partum)
•Paralytic ileus
•Congenital megacolon
•It can be given orally(5, 25, 50 mg tablets), parenteral (5
mg/mL) or topically(0.01% solution)
•Adverse effects: headache, flushing, diarrhea, sweating,
hypotension, urinary urgency.
21
•Other choline esters(Carbachol & Metacholine) are similar
to Betanechol in all sides.
Uses: Glaucoma
•Contraindications to the use of choline esters
•Bronchial asthma(bronchial constriction and increase
bronchial secretions)
•Peptic ulcer disease(increase in gastric acid secretion)
•Coronary insufficiency(compromise coronary blood flow)
•Hyperthyroidism
22
Pilocarpine
•Pilocarpine is a naturally occurring cholinomimetic
alkaloid
•MOA: it directly stimulates the muscarinic receptors to
bring about all the muscarinic effects of acetylcholine.
•It crosses the blood-brain barrier.
•Therapeutic uses: it is primarily used in ophthalmology
•It is the first choice among cholinomimetics for the
treatment of glaucoma.
•Post operative urine retention
•Xerostomia
•It is given orally(5 mg tablets) or topically(10% solutions)
Uses of Indirect acting Cholinergic agents
1. Diagnosis of myasthenia gravis(Edrophonium)
2. Treatment of myasthenia gravis (Neostigmine,
physostigmine, Pyridostigmine, ambenonium,)
3. Antidote Anticholinegics e.g
Atropine(Neostigmine, physostigmine,
Pyridostigmine, ambenonium,)
4. Antidote of Skeletal muscle relaxants
(Neostigmine)
5. Management of Alzheimer's disease(Tacrine,
donepezil, rivastigmine, and galantamine)
6/13/2016 24
Adverse effects of cholinergic agonists
Miosis
Sweating,
Salivation,
Flushing,
Decreased blood pressure,
Nausea,
Abdominal pain,
Diarrhea,
Bronchospasm
CNS disturbances

Contenu connexe

Tendances

Serotonin : diseases and therapeutics
Serotonin : diseases and therapeuticsSerotonin : diseases and therapeutics
Serotonin : diseases and therapeuticsGaurav Yadav
 
Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]Megh Vithalkar
 
SEROTONIN (5-HT) NEUROTRANSMITTER
SEROTONIN (5-HT) NEUROTRANSMITTER �SEROTONIN (5-HT) NEUROTRANSMITTER �
SEROTONIN (5-HT) NEUROTRANSMITTER Aminu Kende
 
NEUROBIOLOGY OF DEPRESSION .pptx
NEUROBIOLOGY OF DEPRESSION  .pptxNEUROBIOLOGY OF DEPRESSION  .pptx
NEUROBIOLOGY OF DEPRESSION .pptxTapendra Satpathy
 
ANS pharmacology ppt
ANS pharmacology pptANS pharmacology ppt
ANS pharmacology pptMANISH mohan
 
Gaba receptors & drugs acting on them
Gaba receptors & drugs acting on themGaba receptors & drugs acting on them
Gaba receptors & drugs acting on themchandiniyrao
 
Serotonergic system ravi
Serotonergic system raviSerotonergic system ravi
Serotonergic system raviPrashant Mishra
 
Clinical use of neuromuscular blocking agents in critically ill patients - NMDA
Clinical use of neuromuscular blocking agents in critically ill patients - NMDAClinical use of neuromuscular blocking agents in critically ill patients - NMDA
Clinical use of neuromuscular blocking agents in critically ill patients - NMDAAreej Abu Hanieh
 
L-Glutamate
L-GlutamateL-Glutamate
L-Glutamatesai nath
 
NMDA receptors and drugs acting on them
NMDA receptors and drugs acting on themNMDA receptors and drugs acting on them
NMDA receptors and drugs acting on themDr. Pooja
 
Serotonin receptors
Serotonin receptorsSerotonin receptors
Serotonin receptorsFarazaJaved
 
Pharmacotherapy of schizophrenia
Pharmacotherapy of schizophreniaPharmacotherapy of schizophrenia
Pharmacotherapy of schizophreniaPrasheeta V P
 
Serotonin; receptors, function and chemistry
Serotonin; receptors, function and chemistrySerotonin; receptors, function and chemistry
Serotonin; receptors, function and chemistrySamanArab1
 
Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017http://neigrihms.gov.in/
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepilepticsraj kumar
 

Tendances (20)

Serotonin : diseases and therapeutics
Serotonin : diseases and therapeuticsSerotonin : diseases and therapeutics
Serotonin : diseases and therapeutics
 
Serotonin
SerotoninSerotonin
Serotonin
 
Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]
 
SEROTONIN (5-HT) NEUROTRANSMITTER
SEROTONIN (5-HT) NEUROTRANSMITTER �SEROTONIN (5-HT) NEUROTRANSMITTER �
SEROTONIN (5-HT) NEUROTRANSMITTER
 
Glutamate muztaba
Glutamate muztabaGlutamate muztaba
Glutamate muztaba
 
NEUROBIOLOGY OF DEPRESSION .pptx
NEUROBIOLOGY OF DEPRESSION  .pptxNEUROBIOLOGY OF DEPRESSION  .pptx
NEUROBIOLOGY OF DEPRESSION .pptx
 
ANS pharmacology ppt
ANS pharmacology pptANS pharmacology ppt
ANS pharmacology ppt
 
Gaba receptors & drugs acting on them
Gaba receptors & drugs acting on themGaba receptors & drugs acting on them
Gaba receptors & drugs acting on them
 
Serotonergic system ravi
Serotonergic system raviSerotonergic system ravi
Serotonergic system ravi
 
Clinical use of neuromuscular blocking agents in critically ill patients - NMDA
Clinical use of neuromuscular blocking agents in critically ill patients - NMDAClinical use of neuromuscular blocking agents in critically ill patients - NMDA
Clinical use of neuromuscular blocking agents in critically ill patients - NMDA
 
Glutamate
GlutamateGlutamate
Glutamate
 
L-Glutamate
L-GlutamateL-Glutamate
L-Glutamate
 
NMDA receptors and drugs acting on them
NMDA receptors and drugs acting on themNMDA receptors and drugs acting on them
NMDA receptors and drugs acting on them
 
Serotonin receptors
Serotonin receptorsSerotonin receptors
Serotonin receptors
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
 
CNS stimulants and cognition enhancers
CNS stimulants and cognition enhancersCNS stimulants and cognition enhancers
CNS stimulants and cognition enhancers
 
Pharmacotherapy of schizophrenia
Pharmacotherapy of schizophreniaPharmacotherapy of schizophrenia
Pharmacotherapy of schizophrenia
 
Serotonin; receptors, function and chemistry
Serotonin; receptors, function and chemistrySerotonin; receptors, function and chemistry
Serotonin; receptors, function and chemistry
 
Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 

Similaire à AUTONOMIC NERVOUS SYSTEM DR. JAMA copy.pptx

Pharmacology cholinergic agonist
Pharmacology   cholinergic agonistPharmacology   cholinergic agonist
Pharmacology cholinergic agonistMBBS IMS MSU
 
Autonomic nervous system
Autonomic nervous systemAutonomic nervous system
Autonomic nervous systemAhmad Umair
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugsJegan Nadar
 
Autonomic nervous system presentation
Autonomic nervous system presentationAutonomic nervous system presentation
Autonomic nervous system presentationsigei meshack
 
Drugs acting on PNS
Drugs acting on PNSDrugs acting on PNS
Drugs acting on PNSmadan sigdel
 
ANS BY Dr.Amruta Nitin Kumbhar
ANS BY Dr.Amruta Nitin KumbharANS BY Dr.Amruta Nitin Kumbhar
ANS BY Dr.Amruta Nitin KumbharPhysiology Dept
 
Introduction to ans, cholinergics system
Introduction to ans, cholinergics systemIntroduction to ans, cholinergics system
Introduction to ans, cholinergics systemSubramani Parasuraman
 
Drugs acting on the autonomic nervous system 1
Drugs acting on the autonomic nervous system   1Drugs acting on the autonomic nervous system   1
Drugs acting on the autonomic nervous system 1Dr. Marya Ahsan
 
Cholinergic system.pptx
Cholinergic system.pptxCholinergic system.pptx
Cholinergic system.pptxJawadAslam30
 
ANS PHARMACOLOGY BPH 2023.pptx
ANS PHARMACOLOGY BPH  2023.pptxANS PHARMACOLOGY BPH  2023.pptx
ANS PHARMACOLOGY BPH 2023.pptxPharmTecM
 
1. Neurotransmitter-4-BDS.pptx
1. Neurotransmitter-4-BDS.pptx1. Neurotransmitter-4-BDS.pptx
1. Neurotransmitter-4-BDS.pptxRajendra Dev Bhatt
 
CHOLINERGIC TRANSMISSION bph 23.pptx
CHOLINERGIC  TRANSMISSION bph 23.pptxCHOLINERGIC  TRANSMISSION bph 23.pptx
CHOLINERGIC TRANSMISSION bph 23.pptxPharmTecM
 
Autonomic & Somatic Nervous Systems.
Autonomic &Somatic Nervous Systems.Autonomic &Somatic Nervous Systems.
Autonomic & Somatic Nervous Systems. Syed Abdul Naveed
 
Autonomic nervous system
Autonomic nervous systemAutonomic nervous system
Autonomic nervous systembigboss716
 
Basic principles of drugs affecting the cns
Basic principles of drugs affecting the cnsBasic principles of drugs affecting the cns
Basic principles of drugs affecting the cnsDr. Marya Ahsan
 

Similaire à AUTONOMIC NERVOUS SYSTEM DR. JAMA copy.pptx (20)

PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
 
Pharmacology cholinergic agonist
Pharmacology   cholinergic agonistPharmacology   cholinergic agonist
Pharmacology cholinergic agonist
 
ANS.pdf
ANS.pdfANS.pdf
ANS.pdf
 
Autonomic nervous system
Autonomic nervous systemAutonomic nervous system
Autonomic nervous system
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
 
Autonomic nervous system presentation
Autonomic nervous system presentationAutonomic nervous system presentation
Autonomic nervous system presentation
 
Drugs acting on PNS
Drugs acting on PNSDrugs acting on PNS
Drugs acting on PNS
 
IVMS Autonomic Nervous System Notes
IVMS Autonomic Nervous System NotesIVMS Autonomic Nervous System Notes
IVMS Autonomic Nervous System Notes
 
ANS BY Dr.Amruta Nitin Kumbhar
ANS BY Dr.Amruta Nitin KumbharANS BY Dr.Amruta Nitin Kumbhar
ANS BY Dr.Amruta Nitin Kumbhar
 
Introduction to ans, cholinergics system
Introduction to ans, cholinergics systemIntroduction to ans, cholinergics system
Introduction to ans, cholinergics system
 
Drugs acting on the cns
Drugs acting on the cnsDrugs acting on the cns
Drugs acting on the cns
 
Drugs acting on the autonomic nervous system 1
Drugs acting on the autonomic nervous system   1Drugs acting on the autonomic nervous system   1
Drugs acting on the autonomic nervous system 1
 
Organization of ans
Organization of ansOrganization of ans
Organization of ans
 
Cholinergic system.pptx
Cholinergic system.pptxCholinergic system.pptx
Cholinergic system.pptx
 
ANS PHARMACOLOGY BPH 2023.pptx
ANS PHARMACOLOGY BPH  2023.pptxANS PHARMACOLOGY BPH  2023.pptx
ANS PHARMACOLOGY BPH 2023.pptx
 
1. Neurotransmitter-4-BDS.pptx
1. Neurotransmitter-4-BDS.pptx1. Neurotransmitter-4-BDS.pptx
1. Neurotransmitter-4-BDS.pptx
 
CHOLINERGIC TRANSMISSION bph 23.pptx
CHOLINERGIC  TRANSMISSION bph 23.pptxCHOLINERGIC  TRANSMISSION bph 23.pptx
CHOLINERGIC TRANSMISSION bph 23.pptx
 
Autonomic & Somatic Nervous Systems.
Autonomic &Somatic Nervous Systems.Autonomic &Somatic Nervous Systems.
Autonomic & Somatic Nervous Systems.
 
Autonomic nervous system
Autonomic nervous systemAutonomic nervous system
Autonomic nervous system
 
Basic principles of drugs affecting the cns
Basic principles of drugs affecting the cnsBasic principles of drugs affecting the cns
Basic principles of drugs affecting the cns
 

Plus de NadiirMahamoud

pathology-environmentalnutritionaldisease-101201075746-phpapp02.pdf
pathology-environmentalnutritionaldisease-101201075746-phpapp02.pdfpathology-environmentalnutritionaldisease-101201075746-phpapp02.pdf
pathology-environmentalnutritionaldisease-101201075746-phpapp02.pdfNadiirMahamoud
 
adnan1-181227181537.pdf
adnan1-181227181537.pdfadnan1-181227181537.pdf
adnan1-181227181537.pdfNadiirMahamoud
 
cell adaptation and cell injury - Copy-4 copy.pptx
cell adaptation and cell injury - Copy-4 copy.pptxcell adaptation and cell injury - Copy-4 copy.pptx
cell adaptation and cell injury - Copy-4 copy.pptxNadiirMahamoud
 
epidemilology of dental caries 2 copy.pptx
epidemilology of dental caries 2 copy.pptxepidemilology of dental caries 2 copy.pptx
epidemilology of dental caries 2 copy.pptxNadiirMahamoud
 
Antibiotics DR. JAMA chep 1.pptx
Antibiotics DR. JAMA chep 1.pptxAntibiotics DR. JAMA chep 1.pptx
Antibiotics DR. JAMA chep 1.pptxNadiirMahamoud
 
Head and neck chapter 13 copy.pptx
Head and neck chapter 13 copy.pptxHead and neck chapter 13 copy.pptx
Head and neck chapter 13 copy.pptxNadiirMahamoud
 
immunodeficiencyppt-170409084703.pptx
immunodeficiencyppt-170409084703.pptximmunodeficiencyppt-170409084703.pptx
immunodeficiencyppt-170409084703.pptxNadiirMahamoud
 
immundeficiencydiseases-160925065412.pdf
immundeficiencydiseases-160925065412.pdfimmundeficiencydiseases-160925065412.pdf
immundeficiencydiseases-160925065412.pdfNadiirMahamoud
 
chapter2basicimmunologypptsdz20102-190704152355.pdf
chapter2basicimmunologypptsdz20102-190704152355.pdfchapter2basicimmunologypptsdz20102-190704152355.pdf
chapter2basicimmunologypptsdz20102-190704152355.pdfNadiirMahamoud
 
emotionandmoods-191007041300.pptx
emotionandmoods-191007041300.pptxemotionandmoods-191007041300.pptx
emotionandmoods-191007041300.pptxNadiirMahamoud
 
chapter 3 Demography.pptx
chapter 3 Demography.pptxchapter 3 Demography.pptx
chapter 3 Demography.pptxNadiirMahamoud
 

Plus de NadiirMahamoud (13)

pathology-environmentalnutritionaldisease-101201075746-phpapp02.pdf
pathology-environmentalnutritionaldisease-101201075746-phpapp02.pdfpathology-environmentalnutritionaldisease-101201075746-phpapp02.pdf
pathology-environmentalnutritionaldisease-101201075746-phpapp02.pdf
 
adnan1-181227181537.pdf
adnan1-181227181537.pdfadnan1-181227181537.pdf
adnan1-181227181537.pdf
 
cell adaptation and cell injury - Copy-4 copy.pptx
cell adaptation and cell injury - Copy-4 copy.pptxcell adaptation and cell injury - Copy-4 copy.pptx
cell adaptation and cell injury - Copy-4 copy.pptx
 
epidemilology of dental caries 2 copy.pptx
epidemilology of dental caries 2 copy.pptxepidemilology of dental caries 2 copy.pptx
epidemilology of dental caries 2 copy.pptx
 
Antibiotics DR. JAMA chep 1.pptx
Antibiotics DR. JAMA chep 1.pptxAntibiotics DR. JAMA chep 1.pptx
Antibiotics DR. JAMA chep 1.pptx
 
Head and neck chapter 13 copy.pptx
Head and neck chapter 13 copy.pptxHead and neck chapter 13 copy.pptx
Head and neck chapter 13 copy.pptx
 
immunodeficiencyppt-170409084703.pptx
immunodeficiencyppt-170409084703.pptximmunodeficiencyppt-170409084703.pptx
immunodeficiencyppt-170409084703.pptx
 
immundeficiencydiseases-160925065412.pdf
immundeficiencydiseases-160925065412.pdfimmundeficiencydiseases-160925065412.pdf
immundeficiencydiseases-160925065412.pdf
 
chapter2basicimmunologypptsdz20102-190704152355.pdf
chapter2basicimmunologypptsdz20102-190704152355.pdfchapter2basicimmunologypptsdz20102-190704152355.pdf
chapter2basicimmunologypptsdz20102-190704152355.pdf
 
emotionandmoods-191007041300.pptx
emotionandmoods-191007041300.pptxemotionandmoods-191007041300.pptx
emotionandmoods-191007041300.pptx
 
chapter 3 Demography.pptx
chapter 3 Demography.pptxchapter 3 Demography.pptx
chapter 3 Demography.pptx
 
FLUORIDE copy.pptx
FLUORIDE copy.pptxFLUORIDE copy.pptx
FLUORIDE copy.pptx
 
chapter one copy.pptx
chapter one copy.pptxchapter one copy.pptx
chapter one copy.pptx
 

Dernier

Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 

Dernier (20)

Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 

AUTONOMIC NERVOUS SYSTEM DR. JAMA copy.pptx

  • 1. Drugs Affecting The Autonomic Nervous System DR.JAMA
  • 3.
  • 4. NERVOUS SYSTEM •The nervous system is divided into two parts: the central nervous system (CNS) and the peripheral nervous system (PNS). •The CNS consists of the brain and spinal cord. •The PNS consists of afferent(sensory) and efferent(motor) neurons. •Afferent (sensory) neurons carry nerve impulses into the CNS from sensory end organs. •Efferent (motor) neurons carry nerve impulses from the CNS to effector cells in peripheral tissues.
  • 5. Cont… •The peripheral efferent system is further divided into the somatic nervous system and the autonomic nervous system which control voluntary and involuntary functions respectively •The autonomic nervous system is subdivided into two major sub-divisions; this classification is based on both anatomic and physiologic grounds: • Sympathetic (Adrenergic)Nervous System(SNS) • Parasympathetic (Cholinergic) Nervous System(PNS)
  • 6. The Autonomic Nervous System Sympathetic (Adrenergic) N S • Arises from thoracic & lumbar areas of the spinal cord. • Concerned with the expenditure of energy & it is associated with arousal or emergency situations, i.e. prepares the body for fight or flight responses Parasympathetic (Cholinergic) N S • Arises from the cranial and sacral of the spinal cord. • Concerned with the conservative & restoration of functions, i.e. prepare the body for rest • Digestive processes & elimination of wastes, and is required for life.
  • 7.
  • 8.
  • 9. Nerve Transmission •There are two important neurotransmitters in the autonomic nervous system. • Acetylcholine and • Noradrenaline (norepinephrine) •Acetylcholine • Released after stimulation of the PNS to act •On effector organs (cells) to elicit their response •As a neurotransmitter: • At all preganglionic neurons of both SNS & PNS
  • 10. Cont… • The effect of PNS activity in an organ is produced either by •Stimulation of a parasympathetic nerve fibers supplying the organ or •The application of acetylcholine or other parasympathomimetics to the effector cells. •This is known as cholinergic activity. •Norepinephrine •Released by postganglionic sympathetic nerves to elicit its effect on effectors cells. •Acts as a neurotransmitters at •Most postganglionic sympathetic nerve ending •Adrenal medullary nerve ending
  • 11. Cont… •Sympathetic nerve activity is produced by •Sympathetic nerve stimulation or •Application of noradrenaline or adrenaline or other sympathomimetics, i.e. ‘adrenergic activity. • These neurotransmitters have different receptors but there are two basic categories of receptors associated with the ANS: •Cholinergic receptors: M and N receptors •Adrenergic receptors: Alpha and Beta
  • 12. Cont… Cholinergic receptors • Are those receptors that mediate responses to acetylcholine • Cholinergic receptors for Ach are classified into • Muscarinic R.( most autonomic effector cells) • Nicotinic R.( ganglia and skeletal muscles) Adrenergic receptors • Are those receptors that mediate responses to norepinephrine • Adrenergic receptors for norepinephrine are •Alpha R.(α) •Beta R.(β)
  • 13. •Agents that increase the activity of Ach or stimulate Parasympathetic nerve system are known as Parasympathomimetics or Cholinergic agonist •Those work against this are known as Parasympatholytics or Anticholinergics •The agents which increase the activity of Epinephrine and norepinephrine are known as sympathomimetics or Adrenergic agonists •and those which oppose are called Sympatholytics or Adrenergic antagonists 13
  • 14. Drugs Acting on Parasympathetic(Cholinergic) system Neurotransmission at Cholinergic Neurons Neurotransmission in cholinergic neurons involves six steps: 1) Synthesis, 2) Storage, 3) Release, 4) Binding of acetylcholine to a receptor, 5) Degradation of the neurotransmitter in the synaptic cleft (that is, the space between the nerve endings and adjacent receptors located on nerves or effector organs), 6) Recycling of choline and acetate 14
  • 15. Cholinergic Receptors A. Muscarinic receptors They have high affinity for muscarine and low affinity for Nicotine There are five subclasses of muscarinic receptors. However, only M1, M2, and M3 receptors have been functionally characterized. Locations Ganglia of PNS and autonomic effector organ such as Heart , smooth muscle, brain, Exocrine glands M1: Gastric parietal cell M2: Cardiac smooth muscle M3: bladder, exocrine glands(sweat ,salivary), bronchial tree, eye, gastrointestinal tract. 15
  • 16. B) Nicotinic Receptors Have high affinity for Nicotine and low affinity for Muscarine Located in CNS, Adrenal medulla, Autonomic ganglia, Neuromuscular junction NMJ in skeletal muscles 16
  • 17. 1. Cholinergic Agonists(Parasympathomimetics) • Result in an increase in the parasympathetic activities in the systems innervated by cholinergic nerves. • There are two groups of cholinergic Agonists: 1. Direct-acting: bind to and activate muscarinic or nicotinic receptors (mostly both) and include the following subgroups: • Esters of choline: Acetylcholine, methacholine, carbachol, betanechol • Cholinergic alkaloids: pilocarpine, muscarine, nicotine 2. Indirect-acting: inhibit the action of acetylcholinesterase enzyme • Reversible: Neostigmine, physostigmine, Edrophonium Pyridostigmine, ambenonium, Tacrine, donepezil, rivastigmine, and galantamine • Irreversible: Organophosphate compounds; Echothiophate, 17
  • 18. Esters of choline ACETYLCHOLINE • It is the prototype of all cholinergic agents. • It is ineffective if given orally, but given parenteral. • MECHANISM OF ACTION(MOA): • It has two types of actions: nicotinic and muscarinic; the muscarinic actions are of main interest. • CVS: slow HR, vasodilate Blood vessels(arterial smooth muscle) thus decrease BP. • GIT: It stimulates the tone and motility of the Gl tract but relaxes the sphincters. • Urinary tract: It stimulates the detrusor muscle and relaxes the urethral sphincter resulting in evacuation of bladder. • Bronchioles: It increase bronchial secretion and brings about bronchoconstriction 18
  • 19. •Eye: It has two effects- miosis and accommodation for near objects because of stimulation of the constrictor pupillae and ciliary muscles respectively. •Exocrine glands: it stimulates salivary, gastric, bronchial, lachrymal and sweat gland secretions. 19
  • 20. Synthetic Choline Esters •These Include: •Metacholine •Carbachol •Betanechol •These drugs have the following advantages over acetylcholine: They have longer duration of action, They are effective orally as well as parenterally, and They are relatively more selective in their actions
  • 21. Betanechol • MECHANISM OF ACTION(MOA): •It has similar actions to those of acetylcholine with pronounced effects on the GIT and the urinary bladder. •Therapeutic uses: •Retention of urine (postoperative, post partum) •Paralytic ileus •Congenital megacolon •It can be given orally(5, 25, 50 mg tablets), parenteral (5 mg/mL) or topically(0.01% solution) •Adverse effects: headache, flushing, diarrhea, sweating, hypotension, urinary urgency. 21
  • 22. •Other choline esters(Carbachol & Metacholine) are similar to Betanechol in all sides. Uses: Glaucoma •Contraindications to the use of choline esters •Bronchial asthma(bronchial constriction and increase bronchial secretions) •Peptic ulcer disease(increase in gastric acid secretion) •Coronary insufficiency(compromise coronary blood flow) •Hyperthyroidism 22
  • 23. Pilocarpine •Pilocarpine is a naturally occurring cholinomimetic alkaloid •MOA: it directly stimulates the muscarinic receptors to bring about all the muscarinic effects of acetylcholine. •It crosses the blood-brain barrier. •Therapeutic uses: it is primarily used in ophthalmology •It is the first choice among cholinomimetics for the treatment of glaucoma. •Post operative urine retention •Xerostomia •It is given orally(5 mg tablets) or topically(10% solutions)
  • 24. Uses of Indirect acting Cholinergic agents 1. Diagnosis of myasthenia gravis(Edrophonium) 2. Treatment of myasthenia gravis (Neostigmine, physostigmine, Pyridostigmine, ambenonium,) 3. Antidote Anticholinegics e.g Atropine(Neostigmine, physostigmine, Pyridostigmine, ambenonium,) 4. Antidote of Skeletal muscle relaxants (Neostigmine) 5. Management of Alzheimer's disease(Tacrine, donepezil, rivastigmine, and galantamine) 6/13/2016 24
  • 25. Adverse effects of cholinergic agonists Miosis Sweating, Salivation, Flushing, Decreased blood pressure, Nausea, Abdominal pain, Diarrhea, Bronchospasm CNS disturbances

Notes de l'éditeur

  1. The simplest distinction the neurons of the somatic division innervate skeletal muscle, the autonomic neurons innervate smooth and cardiac muscle, glands, and neurons in the gastrointestinal tract